These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 36328437)
1. Clinical and Serological Characteristics of Ocular Toxoplasmosis in the Democratic Republic of Congo. Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Mumba Ngoyi D; Kilangalanga Ngoy J; Ngoyi Bambi MT; Kadima Mutombo T; Kintoki Makela G; Ngandowe Nzamokili L; de-la-Torre A Ocul Immunol Inflamm; 2023 Sep; 31(7):1522-1527. PubMed ID: 36328437 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for ocular toxoplasmosis among uveitis patients in Kinshasa, DR Congo. Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Mumba Ngoyi D; Akilimali Zalagile P; de-la-Torre A BMJ Open Ophthalmol; 2023 Jan; 8(1):. PubMed ID: 37278432 [TBL] [Abstract][Full Text] [Related]
3. [Epidemiology and clinical pattern of ocular toxoplasmosis in Kinshasa]. Nsiangani Lusambo N; Kaimbo Wa Kaimbo D J Fr Ophtalmol; 2019 Oct; 42(8):900-906. PubMed ID: 31248609 [TBL] [Abstract][Full Text] [Related]
4. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of trimethoprim/ sulfamethoxazole treatment for ocular toxoplasmosis in Congolese patients. Nsiangani Lusambo N; Kaimbo Wa Kaimbo D; Ngoyi Mumba DM; de-la-Torre A BMC Ophthalmol; 2023 Oct; 23(1):440. PubMed ID: 37907920 [TBL] [Abstract][Full Text] [Related]
6. Cuban Ocular Toxoplasmosis Epidemiology Study (COTES): incidence and prevalence of ocular toxoplasmosis in Central Cuba. Bustillo JL; Diaz JD; Pacheco IC; Gritz DC Br J Ophthalmol; 2015 Mar; 99(3):382-6. PubMed ID: 25253767 [TBL] [Abstract][Full Text] [Related]
7. Patterns of ocular toxoplasmosis presenting at a tertiary eye care center in Korean patients. Kim M; Choi SY; Won JY; Park YH Medicine (Baltimore); 2018 Apr; 97(15):e0399. PubMed ID: 29642204 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis. Cifuentes-González C; Rojas-Carabali W; Pérez ÁO; Carvalho É; Valenzuela F; Miguel-Escuder L; Ormaechea MS; Heredia M; Baquero-Ospina P; Adan A; Curi A; Schlaen A; Urzua CA; Couto C; Arellanes L; de-la-Torre A PLoS One; 2023; 18(4):e0283845. PubMed ID: 37011101 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, visual acuity outcomes, and factors associated with loss of vision among patients with active ocular toxoplasmosis: A retrospective study in a Thai tertiary center. Sittivarakul W; Treerutpun W; Tungsattayathitthan U PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012232. PubMed ID: 38843299 [TBL] [Abstract][Full Text] [Related]
10. [Ocular toxoplasmosis in infants 0 to 12 months of age with congenital toxoplasmosis]. González V L; Cardozo S O; Samudio A M; Mesquita R M Rev Chilena Infectol; 2022 Jun; 39(3):265-272. PubMed ID: 36156688 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. London NJ; Hovakimyan A; Cubillan LD; Siverio CD; Cunningham ET Eur J Ophthalmol; 2011; 21(6):811-9. PubMed ID: 21374556 [TBL] [Abstract][Full Text] [Related]
12. Toxoplasmic retinochoroiditis in an Italian referral center. Accorinti M; Bruscolini A; Pirraglia MP; Liverani M; Caggiano C Eur J Ophthalmol; 2009; 19(5):824-30. PubMed ID: 19787604 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Positive Findings of Park SW; Kim SH; Kwon HJ; Lee SM; Byon IS; Lee JE Ocul Immunol Inflamm; 2019; 27(4):583-590. PubMed ID: 29513626 [No Abstract] [Full Text] [Related]
14. Toxoplasma serotype is associated with development of ocular toxoplasmosis. Shobab L; Pleyer U; Johnsen J; Metzner S; James ER; Torun N; Fay MP; Liesenfeld O; Grigg ME J Infect Dis; 2013 Nov; 208(9):1520-8. PubMed ID: 23878321 [TBL] [Abstract][Full Text] [Related]
15. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia. Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847 [TBL] [Abstract][Full Text] [Related]
16. Monitoring of visual field over 6 months after active ocular toxoplasmosis. Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491 [TBL] [Abstract][Full Text] [Related]
17. [Atypical ocular toxoplasmosis in a Congolese woman of 72 years: report of a case]. Bienvenu YA; Angel MN; Eric KI; Socrate KM; Sebastien MM; Philippe CM; Leon KN; Bruno IO; Gaby CB Pan Afr Med J; 2015; 22():267. PubMed ID: 26958130 [TBL] [Abstract][Full Text] [Related]
18. Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo. Doudou Y; Renaud P; Coralie L; Jacqueline F; Hypolite S; Hypolite M; Patrick M; Andreia Ida L; Van Sprundel M; Marleen B; Van Geertruyden JP; Pascal L Asian Pac J Trop Biomed; 2014 Jan; 4(1):69-74. PubMed ID: 24144134 [TBL] [Abstract][Full Text] [Related]